Amgen Inc . (NASDAQ:AMGN), a leading biopharmaceutical company with a market capitalization of $149 billion, is navigating a ...

NATICK, Mass. - Allurion Technologies, Inc. (NYSE: ALUR), known for its efforts in combating obesity and maintaining ...

The focus on how BMI should be used may have overshadowed an equally, if not more important, matter proposed in a new report.

A major new study has revealed a long list of benefits and some little-known risks of Ozempic and other GLP-1 medications.

Overweight scores continue from 25-30. And over 30 is obese. Quetelet merely used this early calculation as a descriptor. He did not make any medical proclamations. The Quetelet Index became ...

Just as quickly, investors are losing their appetite for the trade. After a disappointing trial of a new Novo Nordisk drug ...

Experts said "unhealthy habits" and "risk taking behaviour" could be a partial cause, with more supported needed for those ...

GLP-1 agonist initiators had a significantly higher likelihood of undergoing thyroid ultrasonography at 6 and 12 months, suggesting detection bias was behind the increased cancer diagnosis rate ...

Popular GLP-1 medications approved for weight loss, diabetes, and heart disease may have untapped potential to treat ...

If you’ve been diagnosed with major depressive disorder, seasonal affective depression or any other type of depression, your ...

Following an "early" time-restricted intermittent fasting pattern is more beneficial for improved blood sugar regulation, and reducing the amount of abdominal fat just under the skin, a new study has ...

The reason is unclear but experts say those with the condition often engage in unhealthy habits and struggle to access health care.